Comparing 3T and 1.5T MRI for mapping hippocampal atrophy in the Alzheimer's disease neuroimaging initiative

67Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND AND PURPOSE: Prior MR imaging studies, primarily at 1.5T, established hippocampal atrophy as a biomarker for Alzheimer disease. 3T MR imaging offers a higher contrast and signal-to-noise ratio, yet distortions and intensity uniformity are harder to control. We applied our automated hippocampal segmentation technique to 1.5T and 3T MR imaging data, to determine whether hippocampal atrophy detection was enhanced at 3T. MATERIALS AND METHODS: We analyzed baseline MR imaging data from 166 subjects from the Alzheimer's Disease Neuroimaging Initiative-1 (37 with Alzheimer disease, 76 with mild cognitive impairment, and 53 healthy controls) scanned at1.5T and 3T. Using multiple linear regression, we analyzed the effect of clinical diagnosis on hippocampal radial distance, while adjusting for sex. 3D statistical maps were adjusted for multiple comparisons by using permutation-based statistics at a threshold of P

Cite

CITATION STYLE

APA

Chow, N., Hwang, K. S., Hurtz, S., Green, A. E., Somme, J. H., Thompson, P. M., … Apostolova, L. G. (2015). Comparing 3T and 1.5T MRI for mapping hippocampal atrophy in the Alzheimer’s disease neuroimaging initiative. American Journal of Neuroradiology, 36(4), 653–660. https://doi.org/10.3174/ajnr.A4228

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free